Related references
Note: Only part of the references are listed.Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice
Se-Hoon Lee et al.
NATURE MICROBIOLOGY (2021)
Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation
Stefano Romano et al.
NPJ PARKINSONS DISEASE (2021)
Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3
Francesco Beghini et al.
ELIFE (2021)
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Lisa Derosa et al.
CANCER DISCOVERY (2021)
Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly
Nicolai Karcher et al.
GENOME BIOLOGY (2021)
Lower Airway Dysbiosis Affects Lung Cancer Progression
Jun-Chieh J. Tsay et al.
CANCER DISCOVERY (2021)
Akkermansia muciniphila reduces Porphyromonas gingivalis-induced inflammation and periodontal bone destruction
Olivier Huck et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2020)
Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Sohyun Hwang et al.
SCIENTIFIC REPORTS (2020)
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa et al.
EUROPEAN UROLOGY (2020)
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Shirish Gadgeel et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation
Jing Ouyang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Subduction initiation and the rise of the Shillong Plateau
Rishav Mallick et al.
EARTH AND PLANETARY SCIENCE LETTERS (2020)
Analysis of compositions of microbiomes with bias correction
Huang Lin et al.
NATURE COMMUNICATIONS (2020)
Antibiotics impair immunotherapy for urothelial cancer
Lisa Derosa et al.
NATURE REVIEWS UROLOGY (2020)
Gut bacteriaAkkermansiais associated with reduced risk of obesity: evidence from the American Gut Project
Qi Zhou et al.
NUTRITION & METABOLISM (2020)
Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
Brendan A. Daisley et al.
NATURE COMMUNICATIONS (2020)
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer
Taiki Hakozaki et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance
Linlin Shi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
IAP inhibitor, Embelin increases VCAM-1 levels on the endothelium, producing lymphocytic infiltration and antitumor immunity
Kosei Nakajima et al.
ONCOIMMUNOLOGY (2020)
Immune Microenvironment Differences Between Squamous and Non-squamous Non-small-cell Lung Cancer and Their Influence on the Prognosis
Xiangjiao Meng et al.
CLINICAL LUNG CANCER (2019)
Akkermansia muciniphila ameliorates the age-related decline in colonic mucus thickness and attenuates immune activation in accelerated aging Ercc1-/7 mice
Benthe van der Lugt et al.
IMMUNITY & AGEING (2019)
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
Yueping Jin et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
A. Elkrief et al.
ANNALS OF ONCOLOGY (2019)
Potential roles of gut microbiome and metabolites in modulating ALS in mice
Eran Blacher et al.
NATURE (2019)
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Clara Depommier et al.
NATURE MEDICINE (2019)
Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice
Clea Barcena et al.
NATURE MEDICINE (2019)
The gut microbiome in anorexia nervosa: relevance for nutritional rehabilitation
Anu Ruusunen et al.
PSYCHOPHARMACOLOGY (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L. Derosa et al.
ANNALS OF ONCOLOGY (2018)
The gut microbiota influences anticancer immunosurveillance and general health
Bertrand Routy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Roberto Ferrara et al.
JAMA ONCOLOGY (2018)
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
Jean-David Fumet et al.
BRITISH JOURNAL OF CANCER (2018)
Gut microbiota changes in the extreme decades of human life: a focus on centenarians
Aurelia Santoro et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
New Insights into the Diversity of the Genus Faecalibacterium
Leandro Benevides et al.
FRONTIERS IN MICROBIOLOGY (2017)
Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model
Wenrui Wu et al.
FRONTIERS IN MICROBIOLOGY (2017)
Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
Patrice D. Cani et al.
FRONTIERS IN MICROBIOLOGY (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
Arabella Young et al.
CANCER CELL (2016)
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
Mahesh S. Desai et al.
CELL (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Near-optimal probabilistic RNA-seq quantification
Nicolas L. Bray et al.
NATURE BIOTECHNOLOGY (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice
Yusuke Shono et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Genome-wide Reconstruction of OxyR and SoxRS Transcriptional Regulatory Networks under Oxidative Stress in Escherichia coli K-12 MG1655
Sang Woo Seo et al.
CELL REPORTS (2015)
An integrated catalog of reference genes in the human gut microbiome
Junhua Li et al.
NATURE BIOTECHNOLOGY (2014)
Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes
H. Bjorn Nielsen et al.
NATURE BIOTECHNOLOGY (2014)
Richness of human gut microbiome correlates with metabolic markers
Emmanuelle Le Chatelier et al.
NATURE (2013)
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Koji Atarashi et al.
SCIENCE (2011)
Metagenomic biomarker discovery and explanation
Nicola Segata et al.
GENOME BIOLOGY (2011)
Share Paper
